Cytokines as therapeutic targets in skin inflammation
Wittmann, Miriam McGonagle, D. Werfel, T.
Wittmann, Miriam
McGonagle, D.
Werfel, T.
Publication Date
2014
End of Embargo
Supervisor
Rights
Peer-Reviewed
Yes
Open Access status
closedAccess
Accepted for publication
Institution
Department
Awarded
Embargo end date
Collections
Additional title
Abstract
This review focuses on treatment targets for the most common inflammatory skin diseases, eczema and psoriasis with an emphasis on cytokines expressed in the uppermost layer of the skin which is easily accessible for diagnostic and therapeutic approaches. Recently, a significant body of research has highlighted the influence of the skin barrier and the patients’ microbiome on skin inflammatory responses and we will comment on their impact on mediator regulation. Itch is a prominent dermatology symptom which is influenced by cytokines and can via itch–scratch cycle impact on the skin barrier and mediator expression associated with damage. Taking the contribution of pruritus and superficial skin damage into account, we address cytokines as targets for stratified treatment approaches in subgroups of eczema and psoriasis.
Version
No full-text in the repository
Citation
Wittmann M, McGonagle D and Werfel T (2014) Cytokines as therapeutic targets in skin inflammation. Cytokine & Growth Factor Reviews. 25(4): 443-51.
Link to publisher’s version
Link to published version
Link to Version of Record
Type
Article